Colestipol Alternatives Compared
Colestipol | Fenofibrate | Atorvastatin |
|
---|
Colestipol | Fenofibrate | Atorvastatin |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Hyperlipoproteinemia, High Cholesterol, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Hyperlipoproteinemia Type IIa - Elevated LDL. colestipol may also be used for purposes not... View more |
Prescription only
Fenofibrate is effective at reducing triglyceride levels and increasing HDL cholesterol levels; however, it is less effective than statins at reducing LDL cholesterol levels. Fenofibrate tablets... View more |
Prescription only
Atorvastatin is effective at lowering cholesterol; however, its use may be limited by side effects such as muscle pain. Prescribed for High Cholesterol, High Cholesterol - Familial Heterozygous... View more |
Related suggestions High Cholesterol
Hyperlipoproteinemia
Hyperlipoproteinemia Type IIa, Elevated LDL
Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
|
|||||||||||||||||||||||
More about Colestipol | More about Fenofibrate | More about Atorvastatin | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Colestipol has an average rating of 6.7 out of 10 from a total of 19 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Fenofibrate has an average rating of 5.7 out of 10 from a total of 68 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 37% reported a negative effect. |
Atorvastatin has an average rating of 4.3 out of 10 from a total of 294 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 56% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: colestipol side effects in more detail. |
See also: fenofibrate side effects in more detail. |
See also: atorvastatin side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all colestipol prices |
View all fenofibrate prices |
View all atorvastatin prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Colestid, Colestid Flavored | Antara, Fenoglide, Lipofen, TriCor, Triglide | Atorvaliq, Lipitor | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
20 hours |
14 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 108 drugs are known to interact with colestipol:
|
A total of 144 drugs are known to interact with fenofibrate:
|
A total of 385 drugs are known to interact with atorvastatin:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
April 04, 1977 |
December 31, 1993 |
December 17, 1996 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.